{"id":391066,"date":"2016-09-15T00:00:00","date_gmt":"2016-09-15T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/nrlfon0004-2016-biopharma-pancreatic-cancer-niche-disease-landscape-forecast-g7-2016\/"},"modified":"2026-05-02T11:40:31","modified_gmt":"2026-05-02T11:40:31","slug":"nrlfon0004-2016-biopharma-pancreatic-cancer-niche-disease-landscape-forecast-g7-2016","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/nrlfon0004-2016-biopharma-pancreatic-cancer-niche-disease-landscape-forecast-g7-2016\/","title":{"rendered":"Pancreatic Cancer | Niche Disease Landscape &#038; Forecast | G7 | 2016"},"content":{"rendered":"<p>Pancreatic cancer remains a deadly disease with limited treatment options. The current standards of treatment are mFOLFIRINOX and gemcitabine + Abraxane. Market growth over the forecast period to 2020 will be driven by the premium-priced products Abraxane and Onivyde and then, over the five years to 2025, by the new product introductions of Lynparza and PEGPH20. Longer-term promise lies in emerging dual and multiple combinations of targeted agents, particularly the PD-1 and PD-L1 checkpoint inhibitors.<\/p>\n","protected":false},"template":"","class_list":["post-391066","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-pancreatic-cancer","biopharma-date-858"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391066\/revisions"}],"predecessor-version":[{"id":576872,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391066\/revisions\/576872"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=391066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}